Vir Biotechnology, Inc. (NASDAQ:VIR) Receives $33.57 Average Price Target from Analysts
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target […]
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month price target […]
